126
Views
4
CrossRef citations to date
0
Altmetric
Original

INNATE IMMUNITY IN RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS

Pages 543-547 | Published online: 02 Jul 2009

REFERENCES

  • Smyth RL, Openshaw PJ: Bronchiolitis Lancet. 2006;368:312–322.
  • Simoes EA, Carbonell-Estrany X: Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J. 2003;22(2 Suppl):S13–S18.
  • McNamara PS, Smyth RL: The pathogenesis of respiratory syncytial virus disease in childhood. Br Med Bull. 2002; 61:13–28.
  • Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, , et al.: Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354:541–545.
  • Wilkinson TM, Donaldson GC, Johnston SL, Openshaw PJ, Wedzicha JA: Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:871–876.
  • Dayan PS, Roskind CG, Levine DA, Kuppermann N: Controversies in the management of children with bronchiolitis. Clin Pediatr Emerg Med. 2004;5:41–53.
  • Spann KM, Tran KC, Chi B, Rabin RL, Collins PL: Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol. 2004;78:4363–4369.
  • Bossert B, Marozin S, Conzelmann KK: Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J Virol. 2003;77:8661–8668.
  • Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, Anderson LJ: CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol. 2001;2:732–738.
  • Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, , et al.: Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000;1:398–401.
  • Zhang P, Summer WR, Bagby GJ, Nelson S: Innate immunity and pulmonary host defense. Immunol Rev. 2000;173:39–51.
  • Franke-Ullmann G, Pfortner C, Walter P, Steinmuller C, Lohmann-Matthes ML, Kobzik L, , et al.: Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro. J Immunol. 1995;154:268–280.
  • Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, Koren HS , et al.: Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis. 1995;171:584–592.
  • McNamara PS, Flanagan BF, Selby AM, Hart CA, Smyth RL: Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J. 2004;23:106–112.
  • McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL: Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child. 2003;88:922–926.
  • Fiedler MA, Wernke-Dollries K, Stark JM: Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am J Physiol. 1995;269(6 Pt 1):L865–L872.
  • Jaovisidha P, Peeples ME, Brees AA, Carpenter LR, Moy JN: Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J Immunol. 1999;163:2816–2820.
  • Smyth RL, Mobbs KJ, O'Hea U, Ashby D, Hart CA: Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype. Pediatr Pulmonol. 2002;33:339–346.
  • Bonville CA, Rosenberg HF, Domachowske JB: Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection. Pediatr Allergy Immunol. 1999;10:39–44.
  • Teran LM, Seminario MC, Shute JK, Papi A, Compton SJ, Low JL, , et al.: RANTES, macrophage-inhibitory protein 1alpha, and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma exacerbations in children. J Infect Dis. 1999;179:677–681.
  • Garofalo RP, Patti J, Hintz KA, Hill V, Ogra PL, Welliver RC: Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis. 2001;184:393–399.
  • McNamara PS, Flanagan BF, Hart CA, Smyth RL: Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis. 2005;191:1225–1232.
  • Luster AD, Ravetch JV: Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med. 1987;166:1084–1097.
  • McNamara PS, Flanagan BF, Baldwin LM, Newland P, Hart CA, Smyth RL: Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis 17. Lancet. 2004; 363:1031–1037.
  • McNamara PS, Smyth RL: Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease 3. Drug News Perspect. 2005;18:615–621.
  • Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA: Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol. 2001;75:10730–10737.
  • Gagro A, Tominac M, Krsulovic-Hresic V, Bace A, Matic M, Drazenovic V, , et al.: Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis. Clinical & Experimental Immunology. 2004;135:267–272.
  • Monick MM, Yarovinsky TO, Powers LS, Butler NS, Carter AB, Gudmundsson G, , et al.: Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J Biol Chem. 2003;278:53035–53044.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.